troglitazone has been researched along with 15-deoxyprostaglandin j2 in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 27 (87.10) | 29.6817 |
| 2010's | 4 (12.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LaPointe, MC; Mendez, M | 1 |
| Evers, BM; Farrow, B; Hashimoto, K; Iwamura, T; O'Connor, KL | 1 |
| Albanese, N; Chatterjee, VK; Gamble, JR; Hahn, C; Vadas, MA; Verrier, E; Wadham, C; Wang, L; Xia, P | 1 |
| Fisher, PB; Han, S; Roman, J; Sidell, N | 1 |
| Brunskill, NJ; Chana, RS; Lewington, AJ | 1 |
| Bedford, DF; Bouck, N; Campbell, SC; Henkin, J; Huang, H; Nelius, T; Schneider, A; Shroff, EH; Veliceasa, D; Volpert, OV | 1 |
| Chen, J; Chen, Q; Jiang, H; Shen, J; Shen, X; Sun, T | 1 |
| Hahn, JH; Kim, DJ; Kim, HA; Kim, PH; Lee, HS; Lee, KJ; Ma, KR; Park, JH | 1 |
| Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Oshitani, N; Sasaki, E; Takashima, T; Tominaga, K; Watanabe, T | 1 |
| Chen, F; Hou, M; Huang, R; Lin, D; Lin, Q; Liu, J; Lu, H; Pan, X; Peng, J; Song, Y; Wu, X; Zhang, M; Zheng, J | 1 |
| Maeda, N; Magota, K; Murakami, R; Okumura, K; Osanai, T; Sasaki, S; Toki, T; Tomita, H; Yasujima, M | 1 |
| Appel, S; Bringmann, A; Brossart, P; Grünebach, F; Mirakaj, V; Weck, MM | 1 |
| Arnold, R; König, W | 2 |
| Coyle, AT; Kinsella, BT | 1 |
| Chaffer, CL; Thomas, DM; Thompson, EW; Williams, ED | 1 |
| Jang, Y; Lee, EJ; Lee, KS; Lee, S; Lim, HJ; Park, HY; Park, JH | 1 |
| Akula, SM; Chintalgattu, V; Harris, GS; Katwa, LC | 1 |
| Arnold, R; König, W; Neumann, M | 1 |
| Li, QL; Li, SJ; Li, SY; Shang, T | 1 |
| Chang, ZQ; Li, J; Li, QL; Li, SJ; Li, SY; Rui, GH; Shang, T | 1 |
| Jang, SK; Kim, JH; Kim, WJ | 1 |
| Kim, H; Kim, KH; Yu, JH | 1 |
| Chan, KW; Dai, Y; Ebert, MP; Gu, Q; Lan, HY; Ma, J; Qiao, L; Rocken, C; Wong, BC; Zou, B | 1 |
| Chan, KW; Dai, Y; Gu, Q; Lan, HY; Ma, J; Qiao, L; Wang, J; Wong, BC; Zou, B | 1 |
| Ando, R; Kohri, K; Nagata, D; Nakanishi, M; Naruyama, H; Okada, S; Tozawa, K; Yoshihiro, H | 1 |
| Chen, N; Jin, YM; Wang, WM; Zhang, HD; Zhu, BB | 1 |
| Arnold, N; Bauerschlag, DO; Biernath-Wüpping, J; Bräutigam, K; Jonat, W; Maass, N; Meinhold-Heerlein, I; von Kaisenberg, CS | 1 |
| Li, C; Li, L; Liu, X; Yang, L; Yu, H | 1 |
| Gerner, C; Gruber, S; Haudek-Prinz, V; Hofstätter, E; Jonak, C; Klepeisz, P; Kunstfeld, R; Paulitschke, V; Pehamberger, H; Petzelbauer, P; Schicher, N | 1 |
| Huxlin, KR; Jeon, KI; Phipps, RP; Sime, PJ | 1 |
31 other study(ies) available for troglitazone and 15-deoxyprostaglandin j2
| Article | Year |
|---|---|
PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes.
Topics: Anilides; Animals; Cells, Cultured; Chromans; Cyclooxygenase 2; Gene Expression Regulation; Interleukin-1; Intramolecular Oxidoreductases; Isoenzymes; Myocytes, Cardiac; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin D2; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2003 |
Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator.
Topics: Chromans; Humans; Integrins; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Pancreatic Neoplasms; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Tissue Plasminogen Activator; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2003 |
PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase.
Topics: Animals; Aorta; Cattle; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Chromans; Diabetic Angiopathies; Diacylglycerol Kinase; Diglycerides; Endothelial Cells; Endothelium, Vascular; Enzyme Induction; Glucose; Humans; PPAR gamma; Prostaglandin D2; Protein Kinase C; Protein Kinase C beta; Protein Transport; Recombinant Fusion Proteins; Signal Transduction; Thiazolidinediones; Transfection; Troglitazone; U937 Cells; Umbilical Veins; Vasculitis | 2004 |
Ligands of peroxisome proliferator-activated receptor gamma inhibit lung cancer cell growth and induce apoptosis by stimulation of P21 expression.
Topics: Antineoplastic Agents; Apoptosis; Chromans; Cyclin D1; Humans; Lung Neoplasms; Prostaglandin D2; Proto-Oncogene Proteins p21(ras); Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazolidinediones; Transcription Factors; Troglitazone | 2004 |
Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
Topics: Animals; Cells, Cultured; Chromans; Extracellular Signal-Regulated MAP Kinases; Kidney Tubules, Proximal; Ligands; Opossums; PPAR gamma; Prostaglandin D2; Thiazolidinediones; Transcriptional Activation; Transfection; Troglitazone | 2004 |
Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510.
Topics: Angiogenesis Inhibitors; CD36 Antigens; Cells, Cultured; Chromans; Drug Interactions; Endothelium, Vascular; Humans; Ligands; Microcirculation; Neoplasms; Neovascularization, Pathologic; Peptides; PPAR gamma; Prostaglandin D2; Thiazolidinediones; Thrombospondin 1; Troglitazone; Vasodilator Agents | 2004 |
A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist.
Topics: alpha-Galactosidase; Anilides; Cells, Cultured; Chromans; CREB-Binding Protein; Drug Evaluation, Preclinical; Genes, Reporter; Indomethacin; Ligands; Nuclear Proteins; Oxazoles; Pioglitazone; PPAR gamma; Prostaglandin D2; Protein Binding; Rosiglitazone; Thiazolidinediones; Trans-Activators; Troglitazone; Two-Hybrid System Techniques; Tyrosine; Yeasts | 2004 |
Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-g.
Topics: Antibodies, Blocking; CD36 Antigens; Cells, Cultured; Chromans; Humans; Lipoproteins, LDL; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Monocytes; NF-kappa B; PPAR gamma; Prostaglandin D2; RNA, Messenger; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transcription, Genetic; Troglitazone | 2004 |
Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
Topics: Antibodies, Monoclonal; Apoptosis; Barrett Esophagus; Biopsy; Bisbenzimidazole; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Chromans; Dose-Response Relationship, Drug; Esophageal Neoplasms; G1 Phase; Humans; Immunohistochemistry; Ligands; PPAR gamma; Prostaglandin D2; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Thiazolidinediones; Thymidine; Troglitazone | 2005 |
Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
Topics: Antineoplastic Agents; Chromans; Extracellular Matrix; Humans; Leukemia, Myeloid; Metalloproteases; PPAR gamma; Prostaglandin D2; Thiazolidinediones; Troglitazone; Tumor Cells, Cultured | 2005 |
Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells.
Topics: Blotting, Western; Cells, Cultured; Chromans; Endothelial Cells; Endothelium, Vascular; Gene Expression; Humans; I-kappa B Proteins; Ligands; Microscopy, Fluorescence; Mitochondrial Proton-Translocating ATPases; NF-kappa B; Oxidative Phosphorylation Coupling Factors; PPAR gamma; Prostaglandin D2; Radioimmunoassay; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Stress, Mechanical; Thiazolidinediones; Troglitazone | 2005 |
PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways.
Topics: Blotting, Western; Cell Movement; Chromans; Cytokines; Dendritic Cells; Humans; Hypoglycemic Agents; Mitogen-Activated Protein Kinases; NF-kappa B; PPAR gamma; Prostaglandin D2; Thiazolidinediones; Toll-Like Receptors; Troglitazone | 2005 |
Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells.
Topics: Cell Line, Tumor; Chemokine CCL5; Chemokines, CC; Chromans; Cytokines; Epithelial Cells; Gene Expression; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-1; Interleukin-6; Interleukin-8; NF-kappa B; PPAR gamma; Prostaglandin D2; Respiratory Syncytial Viruses; RNA, Messenger; Thiazolidinediones; Transcription Factor AP-1; Troglitazone; Tumor Necrosis Factor-alpha | 2006 |
Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells.
Topics: Cell Line; Cell Line, Tumor; Chromans; Genes, Reporter; Humans; Leukemia, Erythroblastic, Acute; Luciferases; PPAR gamma; Promoter Regions, Genetic; Prostaglandin D2; Protein Isoforms; Receptors, Thromboxane A2, Prostaglandin H2; Retinoid X Receptor alpha; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription Factor AP-1; Transcription, Genetic; Troglitazone | 2006 |
PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Carcinoma, Transitional Cell; Caspase 3; Caspase 7; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromans; DNA Fragmentation; Humans; Ligands; Male; PPAR gamma; Prostaglandin D2; Prostatic Neoplasms; RNA, Messenger; Thiazolidinediones; Troglitazone; Urinary Bladder Neoplasms | 2006 |
Peroxisome proliferator-activated receptor-gamma agonists inhibit the replication of respiratory syncytial virus (RSV) in human lung epithelial cells.
Topics: Chromans; Humans; Lung; PPAR gamma; Prostaglandin D2; Respiratory Mucosa; Respiratory Syncytial Viruses; Thiazolidinediones; Troglitazone; Virus Replication | 2006 |
PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs.
Topics: Actins; Adiponectin; Animals; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; CD36 Antigens; Cells, Cultured; Chromans; Complement Factor D; Fatty Acid-Binding Proteins; Foam Cells; Gene Expression; Hypoglycemic Agents; Lipid Metabolism; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; PPAR alpha; PPAR gamma; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Transfection; Troglitazone; Tropomyosin | 2006 |
PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts.
Topics: Animals; Cells, Cultured; Chromans; Collagen; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Laminin; Male; Microscopy, Fluorescence; Muscle Fibers, Skeletal; Myocardial Infarction; Myocytes, Cardiac; NF-kappa B; PPAR gamma; Prostaglandin D2; Proteoglycans; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidinediones; Troglitazone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2007 |
Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells.
Topics: Amino Acids; Cell Adhesion; Cell Line; Cells, Cultured; Chromans; Dose-Response Relationship, Drug; Down-Regulation; Epithelial Cells; Fluorenes; Humans; Intercellular Adhesion Molecule-1; Lung; NF-kappa B; PPAR gamma; Prostaglandin D2; Respiratory Mucosa; Respiratory Syncytial Virus Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidinediones; Troglitazone; U937 Cells | 2007 |
[Effects of peroxisome proliferator-activated receptor gamma and its ligands on cytotrophoblast invasion in first trimester of pregnancy and mechanism thereof].
Topics: Adult; Cell Movement; Cells, Cultured; Chromans; Female; Humans; Immunohistochemistry; Ligands; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; PPAR gamma; Pregnancy; Pregnancy Trimester, First; Prostaglandin D2; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidinediones; Troglitazone; Trophoblasts | 2007 |
[Effect of peroxisome proliferators-activated receptor gamma ligands on cytotrophoblast invasion in first trimester pregnancy].
Topics: Adult; Cell Movement; Cells, Cultured; Chorionic Villi; Chromans; Female; Gene Expression Regulation, Developmental; Humans; Immunohistochemistry; Ligands; Placenta; PPAR gamma; Pregnancy; Pregnancy Trimester, First; Prostaglandin D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidinediones; Troglitazone; Trophoblasts | 2007 |
Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A.
Topics: Anti-Inflammatory Agents; Arachidonic Acid; Arsenites; Chromans; Cyclopentanes; Cytoplasmic Granules; Dinoprostone; Emetine; Enzyme Inhibitors; Eukaryotic Initiation Factor-2; Eukaryotic Initiation Factor-4A; Gene Expression Regulation; HeLa Cells; Humans; Hypoglycemic Agents; Inflammation; Poly(A)-Binding Proteins; PPAR gamma; Prostaglandin D2; Prostaglandins A; Protein Biosynthesis; Protein Synthesis Inhibitors; Rosiglitazone; Signal Transduction; Sodium Compounds; T-Cell Intracellular Antigen-1; Thiazolidinediones; TNF Receptor-Associated Factor 2; Troglitazone; Tumor Necrosis Factor-alpha | 2007 |
SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Ceruletide; Chromans; Enzyme-Linked Immunosorbent Assay; Interleukin-6; Janus Kinase 2; Male; Pancreas; PPAR gamma; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Thiazolidinediones; Transforming Growth Factor beta1; Troglitazone | 2008 |
Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2.
Topics: Anilides; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspases; Chromans; Colonic Neoplasms; Down-Regulation; HCT116 Cells; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; PPAR gamma; Prostaglandin D2; Thiazolidinediones; Troglitazone; X-Linked Inhibitor of Apoptosis Protein | 2008 |
Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer.
Topics: Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromans; Colonic Neoplasms; Down-Regulation; Humans; Ki-67 Antigen; Ligands; Poly(ADP-ribose) Polymerases; PPAR gamma; Prostaglandin D2; Proteasome Endopeptidase Complex; Thiazolidinediones; Troglitazone; Vascular Endothelial Growth Factor A; X-Linked Inhibitor of Apoptosis Protein; Xenograft Model Antitumor Assays | 2008 |
Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chromans; Flow Cytometry; Humans; Immunohistochemistry; Ligands; Male; PPAR gamma; Promoter Regions, Genetic; Prostaglandin D2; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Thiazolidinediones; Transfection; Troglitazone | 2008 |
PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells.
Topics: Animals; Cell Line; Chemokine CCL2; Chromans; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Hypoglycemic Agents; Interleukin-8; Kidney Tubules, Proximal; PPAR gamma; Prostaglandin D2; Thiazolidinediones; Transforming Growth Factor beta1; Troglitazone | 2009 |
Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines.
Topics: Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Cell Line, Tumor; Chromans; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Ovarian Neoplasms; PPAR gamma; Prostaglandin D2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Thiazolidinediones; TNF-Related Apoptosis-Inducing Ligand; Troglitazone | 2011 |
15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines.
Topics: Acetylcysteine; Anilides; Animals; Cell Line; Cell Proliferation; Chemokine CCL2; Chromans; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; Monocytes; Oxidative Stress; Phagocytosis; PPAR gamma; Prostaglandin D2; Reactive Oxygen Species; Thiazolidinediones; Troglitazone; Tumor Necrosis Factor-alpha | 2012 |
Proteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction.
Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromans; Humans; Melanoma; PPAR gamma; Prostaglandin D2; Proteome; Pyrimidines; Thiazolidinediones; Troglitazone | 2012 |
Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
Topics: Actins; Animals; Blotting, Western; Cats; Cells, Cultured; Chromans; Collagen Type I; Connective Tissue Growth Factor; Corneal Keratocytes; Fibronectins; Hypoglycemic Agents; JNK Mitogen-Activated Protein Kinases; Ligands; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Prostaglandin D2; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta1; Troglitazone | 2015 |